The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a peer reviewed on-line journal and database in free access on internet devoted to genes, cytogenetics, and clinical entities in cancer, and cancer-prone diseases.
http://atlasgeneticsoncology.org/

Chemotherapy protocols, provided by the British Columbia Cancer Agency (BCCA).
http://www.bccancer.bc.ca/HPI/ChemotherapyProtocols/default.htm

Manual of Chemotherapeutics, provided by the British Columbia Cancer Agency (BCCA).
http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/default.htm

Guidelines on hematology
http://www.bcshguidelines.com

Scientific evaluation of complementary and alternative medicine by the National Cancer Institute.
http://www.cancer.gov/cancertopics/treatment/cam

Reliable information on complementary and alternative medicines relating to cancer provided by the European Union (EU).
http://www.cam-cancer.org/

Three databases, the NCI/NCBI SKY/M-FISH & CGH Database, the NCI Mitelman Database of Chromosome Aberrations in Cancer, and the NCI Recurrent Aberrations in Cancer, are now integrated into NCBI's Entrez system as Cancer Chromosomes.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=Home&DB=cancerchromosomes

Database about the human immune response to cancer.
http://www2.licr.org/CancerImmunomeDB/

This website provides access to information on the occurrence of cancer world-wide held by the Unit of Descriptive Epidemiology at the International Agency for Research on Cancer.
http://www-dep.iarc.fr

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics.
http://caonline.amcancersoc.org/cgi/content/full/caac.20073v1?ijkey=d919724d94cb93c2fc5e38c96cbbe62cbf088d50

The 10th Report on Carcinogens is producec by
U.S. Department of Health and Human Services, Public Health Service,
National Toxicology Program
Pursuant to Section 301(b) (4) of the Public Health Service Act as Amended by Section 262, PL 95-622
http://ehp.niehs.nih.gov/roc/toc10.html?viewid=5f35036e-5497-4d86-8c2c-714a9f7c8d25

Chemical Carcinogenesis Research Information System - carcinogenicity, mutagenicity, tumor promotion, and tumor inhibition data provided by the National Cancer Institute (NCI).
http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS

Information about more than 41,000 active industry and government-sponsored clinical trials, as well as new drug therapies in research and those recently approved by the FDA.
http://www.centerwatch.com/

The Cancer Genome Anatomy Project (CGAP) is an interdisciplinary program established and administered by the National Cancer Institute (NCI) to generate the information and technological tools needed to decipher the molecular anatomy of the cancer cell.
http://www.ncbi.nlm.nih.gov/CGAP/

COSMIC (Catalogue of Somatic Mutations in Cancer; http://www.sanger.ac.uk/cosmic) is a comprehensive resource that aims to curate the world's literature on somatic mutations in known cancer genes. The catalog includes full and up-to-date curation of mutation data in over 60 well known point-mutated genes, together with novel gene fusion products expressed across genome rearrangement breakpoints, and all of the somatic mutation data from candidate gene screens at the UK's Cancer Genome Project.
http://www.sanger.ac.uk/cosmic

The CPDB is a standardized resource on chronic, long-term animal cancer tests. CPDB provides ...
- Quick access to results on 1451 chemicals
- Analyses of experimental design for each of 6008 experiments, including species, strain, dose and protocol
-Analyses of tumor incidence at each target site, dose-response curve shape, carcinogenic potency and statistical significance
http://potency.berkeley.edu/cpdb.html

EPIMHC is a relational database of MHC-binding peptides and T cell epitopes that are observed in real proteins. Currently, the database contains 4867 distinct peptide sequences from various sources, including 84 tumor-associated antigens.
http://bio.dfci.harvard.edu/epimhc/

The ESMO Clinical Recommendations (CR) are clinical guidelines intended to provide the user with a set of requirements for a basic standard of cancer care. Each CR offers vital, evidence-based information for physicians, including the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up.
http://www.esmo.org/education/esmo-clinical-practice-guidelines.html

Overview about clinical trials on the field of gene therapy, provided by the Journal of Gene Medicine.
http://www.wiley.co.uk/genmed/clinical/

Registry of cancer trials in Germany.
http://www.studien.de/

Retroviral genomes or parts of their genomes are present in the DNA of many organisms. Studies of endogenous retroviral nucleotide sequences have become an important part of contemporary retrovirology as well as of molecular and cellular biology and genomics. Human endogenous retroviruses (HERVs) are of special interest also because their expression may be associated with several diseases, including cancer. Various groups of HERVs have been reported in the human genome. Their number can range from one copy to many thousand copies.
http://herv.img.cas.cz

The International Cancer Research Portfolio, or ICRP, represents a database of information on cancer research awards of the cancer funding organizations that comprise the International Cancer Research (ICR) Partners.
http://www.cancerportfolio.com/

Integrated Risk Information System - data from the EPA in support of human health risk assessment, focusing on hazard identification and dose-response assessment.
http://www.epa.gov/iris/

To study interplay of DNA methylation, gene expression and cancer, a database for human DNA Methylation and Cancer was developed. MethyCancer hosts both highly integrated data of DNA methylation, cancer-related gene, mutation and cancer information from public resources, and the CpG Island (CGI) clones derived from our large-scale sequencing. Interconnections between different data types were analyzed and presented. Furthermore, a powerful search tool is developed to provide user-friendly access to all the data and data connections. A graphical MethyView shows DNA methylation in context of genomics and genetics data facilitating the research in cancer to understand genetic and epigenetic mechanisms that make dramatic changes in gene expression of tumor cells.
http://methycancer.genomics.org.cn/

A mouse repository/distribution resource at the NCI-Frederick Cancer Research Center that:

The Mouse Tumor Biology (MTB) Database supports the use of the mouse as a model system of hereditary cancer by providing electronic access to:
Descriptions of tumors (data are organized by strain and organ of tumor origin),
Tumor frequency and latency data,
Information on genetic factors associated with tumors and tumor development,
Tumor pathology reports and images,
References, both published and unpublished, and
Links to related online resources including:
http://tumor.informatics.jax.org/FMPro?-db=TumorInstance&-format=mtdp.html&-view

Diese Website enthält Links zu folgenden Datenbanken:

The most famous U.S. cancer centers are affiliated into the National Comprehensive Cancer Network (NCCN). Members are e.g. the Fred Hutchinson Cancer Research Center, the Memorial Sloan-Kettering Cancer Center, the Dana-Farber Cancer Care Center, the M.D. Anderson Cancer Center as well as the City of Hope Cancer Center.
This Site provides carefully compiled guidlines for the diagnosis and treatment of cancer.
http://www.nccn.org/

The NCCN Drugs & Biologics Compendium™ is an important source of information for case managers, managed care decision-makers, and other health care professionals who authorize treatment for patients. Based on the NCCN Clinical Practice Guidelines in Oncology™, the compendium delineates uses of drugs and biologics in the care of cancer patients, listing FDA-approved disease indications and specific NCCN recommendations for use, as well as defining levels of evidence and categories of consensus supporting recommendations.
http://www.nccn.org/professionals/default.asp

A database about investigational drugs, provided by the NCI.
http://dtp.nci.nih.gov/docs/idrugs/chemdata.html

Research Tools and Services, provided by the NCI, National Cancer Institute.
http://resresources.nci.nih.gov/

Clinical trials by the Natioanl Cancer Instiute (NCI).
http://cancer.gov/search/clinical_trials/search_clinicaltrialsadvanced.aspx

NMP-db is a database of nuclear matrix associated proteins, produced by Sven Mika @ Rost Group, Columbia University, New York.
http://www.rostlab.org/db/NMPdb/

This excellent website, made by the Abramson Cancer Center of the University of Pennsylvania, provides a database of clinical cancer trials.
http://www.oncolink.com/treatment/trials.html

Oncology informations produced by Elsevier. About 240 Chemothrapy Regimens are provided.
http://www.oncologystat.com/

ONCOMINE collects all publicly available cancer microarray studies.
http://www.oncomine.org

PDQ (Physician Data Query) is NCI's comprehensive cancer database. It contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care; a registry of approximately 1,800 open and 12,000 closed cancer clinical trials from around the world; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care.
http://cancer.gov/cancerinfo/pdq/adulttreatment

PDQ (Physician Data Query) is NCI's comprehensive cancer database. It contains peer-reviewed summaries on cancer treatment, screening, prevention, genetics, and supportive care; a registry of approximately 1,800 open and 12,000 closed cancer clinical trials from around the world; and directories of physicians, professionals who provide genetics services, and organizations that provide cancer care.
http://cancer.gov/cancerinfo/pdq/adulttreatment

Clinical Trials on the field of oncology.
http://www.cancer.gov/clinicaltrials/

The recurrent aberrations were derived from the Mitelman Database of Chromosome Aberrations in Cancer (2003) and include all cytogenetic changes present in at least two cases of the same morphologic entity, and, whenever applicable for solid tumors, within the same site. The complete karyotypes, patient characteristics, and references are found in the Mitelman Database of Chromosome Aberrations in Cancer.
http://cgap.nci.nih.gov/Chromosomes/RecurrentAberrations

Epidemiologic database by the NCI, USA.
http://seer.cancer.gov/

Spectral Karyotyping (SKY) and Comparative Genomic Hybidization (CGH) are complementary fluorescent molecular cytogenetic techniques that have revolutionized the detection of chromosomal abnormalities. SKY permits the simultaneous visualization of all human or mouse chromosomes in a different color, facilitating the detection of chromosomal translocations and rearrangements. CGH uses the hybridization of differentially labeled tumor and reference DNA to generate a map of DNA copy number changes in tumor genomes.
http://www.ncbi.nlm.nih.gov/sky/

The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing. TCGA is a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are both part of the National Institutes of Health, U.S. Department of Health and Human Services.
http://cancergenome.nih.gov/

Toxicity criteria of the NCI.
http://www.fda.gov/cder/cancer/toxicityframe.htm

In 1991, a database of TP53 somatic mutations in human cancers and cell-lines was initiated by Monica Hollstein and Curtis Harris. Since 1994, this database has been maintained at the International Agency for Research on Cancer (IARC) in Lyon, France and is made freely available as a service to the scientific community.
The IARC TP53 Mutation Database is now maintained by the Unit of Molecular Carcinogenesis (MOC) at IARC, under the supervision of Pierre Hainaut.
The project consists of three aspects:
Perform regular review of the TP53 mutation literature
Develop electronic formats for compiling, sorting and retrieving mutation data
Perform research on TP53 mutation patterns
http://www-p53.iarc.fr/

Chemotherapy protocols, provided by Cancer Care Ontario.
http://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=11128

Tubafrost is the central European database collecting the information of frozen tumor tissue specimens.
http://www.tubafrost.org/

Wnt proteins form a family of highly conserved secreted signaling molecules that regulate cell-to-cell interactions during embryogenesis. Wnt genes and Wnt signaling are also implicated in cancer. Insights into the mechanisms of Wnt action have emerged from several systems: genetics in Drosophila and Caenorhabditis elegans; biochemistry in cell culture and ectopic gene expression in Xenopus embryos. Many Wnt genes in the mouse have been mutated, leading to very specific developmental defects.
http://www.stanford.edu/~rnusse/wntwindow.html